Literature DB >> 29772576

Wake-Up Stroke versus Stroke with Known Onset Time: Clinical and Multimodality CT Imaging Characteristics.

Jan W Dankbaar1, Henri P Bienfait2, Coen van den Berg1, Edwin Bennink1,3, Alexander D Horsch1, Tom van Seeters1, Irene C van der Schaaf1, L Jaap Kappelle4, Birgitta K Velthuis1.   

Abstract

BACKGROUND: Current guidelines for the treatment of acute ischemic stroke are mainly based on the time between symptom onset and initiation of treatment. This time is unknown in patients with wake-up stroke (WUS). We investigated clinical and multimodality CT imaging characteristics on admission in patients with WUS and in patients with a stroke with a known onset time.
METHODS: All patients were selected from a large prospective cohort study (Dutch acute stroke study). WUS patients last seen well > 4.5 and ≤4.5 h were separately compared to patients with a known onset time ≤4.5 h. In addition, WUS patients with a proximal occlusion of the anterior circulation last seen well > 6 and ≤6 h were separately compared to patients with a known onset time ≤6 h and a proximal occlusion. National Institute of Health Stroke Score, age, gender, history of atrial fibrillation, non-contrast CT (NCCT) Alberta Stroke Program Early CT Score (ASPECTS), CT-perfusion abnormalities, proximal occlusions, and collateral filling on CT angiography were compared between groups using the Mann-Whitney U test and Fisher's exact test.
RESULTS: WUS occurred in 149/1,393 (10.7%) patients. Admission clinical and imaging characteristics of WUS patients last seen well > 4.5 h (n = 81) were not different from WUS patients last seen well ≤4.5 h (n = 68). Although WUS patients last seen well > 4.5 h had a significantly lower NCCT ASPECTS than patients with a known time of stroke symptom onset of ≤4.5 h (n = 1,026), 85.2% had an NCCT ASPECTS > 7 and 75% had a combination of favorable ASPECTS > 7 and good collateral filling. There were no statistically significant differences between the admission clinical and imaging characteristics of WUS patients with proximal occlusions last seen well > 6 h (n = 23), last seen well ≤6 h (n = 40), and patients with a known time to stroke symptom onset ≤6 h (n = 399). Of all WUS patients with proximal occlusions last seen well > 6 h, only 4.3% had severe ischemia (ASPECTS < 5), 13 (56.5%) had ASPECTS > 7 and good collateral filling.
CONCLUSIONS: There are only minor differences between clinical and imaging characteristics of WUS patients and patients who arrive in the hospital within the time criteria for intravenous or endovascular treatment. Therefore, CT imaging may help to identify WUS patients who would benefit from treatment and rule out those patients with severe ischemia and poor collaterals.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Acute ischemic stroke; Acute stroke imaging; Computed tomography; Wake-up stroke

Mesh:

Year:  2018        PMID: 29772576      PMCID: PMC6492505          DOI: 10.1159/000489566

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  27 in total

1.  Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core.

Authors:  Bruce C V Campbell; Søren Christensen; Christopher R Levi; Patricia M Desmond; Geoffrey A Donnan; Stephen M Davis; Mark W Parsons
Journal:  Stroke       Date:  2011-10-06       Impact factor: 7.914

2.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score.

Authors:  P A Barber; A M Demchuk; J Zhang; A M Buchan
Journal:  Lancet       Date:  2000-05-13       Impact factor: 79.321

3.  Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.

Authors:  Luisa Roveri; Sara La Gioia; Chiara Ghidinelli; Nicoletta Anzalone; Costantino De Filippis; Giancarlo Comi
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-11-30       Impact factor: 2.136

4.  Population-based study of wake-up strokes.

Authors:  J Mackey; D Kleindorfer; H Sucharew; C J Moomaw; B M Kissela; K Alwell; M L Flaherty; D Woo; P Khatri; O Adeoye; S Ferioli; J C Khoury; R Hornung; J P Broderick
Journal:  Neurology       Date:  2011-05-10       Impact factor: 9.910

5.  CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct.

Authors:  I Y L Tan; A M Demchuk; J Hopyan; L Zhang; D Gladstone; K Wong; M Martin; S P Symons; A J Fox; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2009-01-15       Impact factor: 3.825

6.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

7.  Early CT findings in unknown-onset and wake-up strokes.

Authors:  Kenichi Todo; Hiroshi Moriwaki; Kozue Saito; Makiko Tanaka; Hiroshi Oe; Hiroaki Naritomi
Journal:  Cerebrovasc Dis       Date:  2006-02-15       Impact factor: 2.762

8.  Extent of hypoattenuation on CT angiography source images predicts functional outcome in patients with basilar artery occlusion.

Authors:  Volker Puetz; P N Sylaja; Shelagh B Coutts; Michael D Hill; Imanuel Dzialowski; Pia Mueller; Ulf Becker; Gabriele Urban; Christine O'Reilly; Philip A Barber; Pranshu Sharma; Mayank Goyal; Georg Gahn; Ruediger von Kummer; Andrew M Demchuk
Journal:  Stroke       Date:  2008-07-10       Impact factor: 7.914

9.  Optimal Tmax threshold for predicting penumbral tissue in acute stroke.

Authors:  Jean-Marc Olivot; Michael Mlynash; Vincent N Thijs; Stephanie Kemp; Maarten G Lansberg; Lawrence Wechsler; Roland Bammer; Michael P Marks; Gregory W Albers
Journal:  Stroke       Date:  2008-12-24       Impact factor: 7.914

10.  Difference in tracer delay-induced effect among deconvolution algorithms in CT perfusion analysis: quantitative evaluation with digital phantoms.

Authors:  Kohsuke Kudo; Makoto Sasaki; Kuniaki Ogasawara; Satoshi Terae; Shigeru Ehara; Hiroki Shirato
Journal:  Radiology       Date:  2009-02-03       Impact factor: 11.105

View more
  5 in total

1.  Surrogate biomarkers of outcome for wake-up ischemic stroke.

Authors:  Pablo Hervella; María Luz Alonso-Alonso; María Pérez-Mato; Manuel Rodríguez-Yáñez; Susana Arias-Rivas; Iria López-Dequidt; José M Pumar; Tomás Sobrino; Francisco Campos; José Castillo; Ramón Iglesias-Rey
Journal:  BMC Neurol       Date:  2022-06-09       Impact factor: 2.903

2.  CT Imaging Characteristics and Influence Factors of Renal Dialysis-Associated Peritoneal Injury.

Authors:  Jin Tong; Wangda Xu
Journal:  J Healthc Eng       Date:  2021-04-20       Impact factor: 2.682

Review 3.  Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation.

Authors:  Patrick D Lyden; Kent E Pryor; Jennifer Minigh; Thomas P Davis; John H Griffin; Howard Levy; Berislav V Zlokovic
Journal:  Front Neurol       Date:  2021-03-15       Impact factor: 4.003

4.  Clinical and radiological factors predicting stroke outcome after successful mechanical intervention in anterior circulation.

Authors:  Tomáš Peisker; Peter Vaško; Petr Mikulenka; David Lauer; Boris Kožnar; Jakub Sulženko; Filip Roháč; Dušan Kučera; David Girsa; Karin Kremeňová; Petr Widimský; Ivana Štětkářová
Journal:  Eur Heart J Suppl       Date:  2022-03-30       Impact factor: 1.624

5.  Effect of the Number of Neurointerventionalists on Off-Hour Endovascular Therapy for Acute Ischemic Stroke Within 12 Hours of Symptom Onset.

Authors:  Joong-Goo Kim; Jay Chol Choi; Duk Ju Kim; Hee-Joon Bae; Soo-Joo Lee; Jong-Moo Park; Tai Hwan Park; Yong-Jin Cho; Kyung Bok Lee; Jun Lee; Dong-Eog Kim; Jae-Kwan Cha; Joon-Tae Kim; Byung-Chul Lee
Journal:  J Am Heart Assoc       Date:  2019-10-18       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.